AIDX20/20 Biolabs Inc
Slide 1 of 3
Company Overview
Name
20/20 Biolabs Inc
52W High
$50.00
52W Low
$0.16
Market Cap
$2M
Dividend Yield
0%
Price/earnings
-0.12
P/E
-0.12
Tags
Dividends
No dividend
Sentiment
Score
Mixed
47
Low
Neutral
High
0
50
100
Trade Volume
Score
Neutral
50
Low
Neutral
High
0
50
100
Slide 2 of 3
Income Statement
Total Revenue
$380.2K
Operating Revenue
$380.2K
Total Gross Profit
$96.9K
Total Operating Income
$-1.4M
Net Income
$-1.4M
EV to EBITDA
$0.00
EV to Revenue
$0.14
Price to Book value
$3.33
Price to Earnings
$0.00
Additional Data
Selling, General & Admin Expense
$1.4M
Research & Development Expense
$123.4K
Total Operating Expenses
$-1.5M
Interest Expense
N/A
Interest & Investment Income
$14.8K
Other Income / (Expense), net
N/A
Slide 3 of 3
Earnings History
- Estimated
- Reported, beat
- Reported, missed
Estimated EPS
Reported EPS
N/A Slide 1 of 5
Company Overview
Name
20/20 Biolabs Inc
52W High
$50.00
52W Low
$0.16
Market Cap
$2M
Dividend Yield
0%
Price/earnings
-0.12
P/E
-0.12
Tags
Dividends
No dividend
Slide 2 of 5
Sentiment
Score
Mixed
47
Low
Neutral
High
0
50
100
Trade Volume
Score
Neutral
50
Low
Neutral
High
0
50
100
Slide 3 of 5
Income Statement
Total Revenue
$380.2K
Operating Revenue
$380.2K
Total Gross Profit
$96.9K
Total Operating Income
$-1.4M
Net Income
$-1.4M
EV to EBITDA
$0.00
EV to Revenue
$0.14
Price to Book value
$3.33
Price to Earnings
$0.00
Slide 4 of 5
Additional Data
Selling, General & Admin Expense
$1.4M
Research & Development Expense
$123.4K
Total Operating Expenses
$-1.5M
Interest Expense
N/A
Interest & Investment Income
$14.8K
Other Income / (Expense), net
N/A
Slide 5 of 5
Earnings History
- Estimated
- Reported, beat
- Reported, missed
Estimated EPS
Reported EPS
N/AUpcoming Earnings
We were not able to find an announced earnings date for this symbol yet. Check back again later
Company Info
CEO
Jonathan Cohen
Location
Maryland, USA
Exchange
Nasdaq
Website
https://2020biolabs.com
Summary
We develop and commercialize AI-powered, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases.
Company Info
CEO
Jonathan Cohen
Location
Maryland, USA
Exchange
Nasdaq
Website
https://2020biolabs.com
Summary
We develop and commercialize AI-powered, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases.
Community Research
Research from investors like you
Be the first to share your analysis on AIDX
Help fellow investors make informed decisions by sharing your research on fundamentals, catalysts, and outlook.
Topics: Company overview • Products • Competitors • Strengths & Risks
Symbol's posts
No more topics to show
